Combination Therapy for Neuropathic Pain
Authors:
- 1 December 2011
- journal article
- review article
- Published by Springer Nature in CNS Drugs
- Vol. 25 (12) , 1023-1034
Abstract
Neuropathic pain is a debilitating chronic condition that remains very difficult to treat. Recently, a number of clinical studies have compared the effectiveness of combination drug therapy with monotherapy for neuropathic pain treatment. In this article, we summarize up-to-date clinical studies of combination therapy for the treatment of both cancer- and non-cancer-related neuropathic pain. Despite a relatively small number of clinical studies on this topic, several positive indications have emerged. First, clinical studies using gabapentin (five positive trials) and pregabalin (five positive trials and one negative trial) in combination with an opioid, cyclo-oxygenase-2 inhibitor or antidepressant have shown positive responses greater than the respective monotherapies for pain related to diabetic neuropathy and post-herpetic neuropathy. Second, high-concentration (8%) topical capsaicin and a 5% lidocaine patch seem to be effective add-on therapies (a modality of combination therapy) for various neuropathic pain conditions. Third, combination therapy for cancer-related neuropathic pain has yielded only limited success based on a number of small-scale clinical studies. While there are benefits of using combination therapy for neuropathic pain treatment, including better pain relief and reduced adverse effects, more clinical studies are required in order to (i) make head-to-head comparisons between combination and single-drug therapies, (ii) identify symptom-specific combination therapies for distinctive clinical neuropathic pain conditions, (iii) explore combination therapies that include non-drug modalities such as physical therapy, psychological coping and biofeedback to facilitate functional restoration and (iv) develop new and objective evaluation tools for clinical outcome assessment.Keywords
This publication has 75 references indexed in Scilit:
- Central sensitization: Implications for the diagnosis and treatment of painPain, 2011
- Combination Drug Therapy for Chronic Pain: A Call for More Clinical StudiesThe Journal of Pain, 2011
- A Randomized, Controlled Trial of Oxycodone Versus Placebo in Patients With PostHerpetic Neuralgia and Painful Diabetic Neuropathy Treated With PregabalinThe Journal of Pain, 2010
- Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature UpdateMayo Clinic Proceedings, 2010
- Treatment Considerations for Patients With Neuropathic Pain and Other Medical ComorbiditiesMayo Clinic Proceedings, 2010
- Pregabalin, celecoxib, and their combination for treatment of chronic low-back painJournal of Orthopaedics and Traumatology, 2009
- Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root painPain, 2007
- Pharmacokinetics Following Intraventricular Administration of Chemotherapy in Patients with Neoplastic MeningitisClinical Pharmacokinetics, 2005
- Intrathecal methodsNeurosurgery Clinics of North America, 2004
- Review articleJournal of Pain and Symptom Management, 1998